General Information of the Compound
| Compound ID |
CP0924851
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-2-amino-N-(((S)-3-((R)-1-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-2,4-dioxooxazolidin-5-yl)methyl)-3-(4-hydroxyphenyl)propanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C33H34N6O7
|
||||||||||||||||||
| Molecular Weight |
626.67
|
||||||||||||||||||
| Canonical SMILES |
NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)N1C(=O)O[C@@H](CNC(=O)[C@@H](N)Cc2ccc(O)cc2)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C33H34N6O7/c34-24(14-20-10-12-22(40)13-11-20)30(42)37-18-28-32(44)39(33(45)46-28)27(16-21-17-36-25-9-5-4-8-23(21)25)31(43)38-26(29(35)41)15-19-6-2-1-3-7-19/h1-13,17,24,26-28,36,40H,14-16,18,34H2,(H2,35,41)(H,37,42)(H,38,43)/t24-,26-,27+,28-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UYMUWOSGPSGFAU-WOHWVRMTSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor